Star Health hacker says they sent death threats, bullets to India executives
The hacker, who goes by the alias "xenZen", described their reprisals against Star Health and Allied Insurance Company in a March 31 email to Reuters. The news agency is reporting them for the first time.
Star Health, India's biggest health insurer, has faced criticism from customers and data security experts since Reuters reported last September that xenZen had leaked sensitive client data, including medical reports. At the time, xenZen told Reuters in an email they possessed 7.24 terabytes of data related to over 31 million Star Health customers and was speaking to potential buyers for the data.
The news agency hasn't independently confirmed the identity or location of xenZen, the accuracy of the facts laid out in the March 31 email or the hacker's motive for targeting Star Health and its executives, which the email ascribed to the company's denial of medical claims to certain customers.
In response to questions from Reuters, Star Health's chief legal officer said in a statement the company could not comment "due to an ongoing, highly sensitive criminal investigation" related to its data leak. XenZen said they had concealed bullet cartridges in two packages sent to Star Health's head office in the southern Indian city of Chennai, in Tamil Nadu state, in February.
The email included photographs that showed the packages addressed to Chief Executive Anand Roy and Chief Financial Officer Nilesh Kambli and a note inside which read: "next one will go in ur and ur peoples head. tik tik tik."
Roy did not respond to a phone call requesting comment, while Kambli told Reuters Star Health's public relations team would respond on his behalf. The company did not respond to further requests for comment.
The New Indian Express on Saturday reported that police in Tamil Nadu were investigating the threats and had linked them to xenZen.
Tamil Nadu police did not respond to Reuters queries.
Three Indian police sources confirmed an investigation was underway. They declined to be named as the matter is confidential.
One police source said a man from the neighbouring state of Telangana, who the source did not name, has been arrested in recent days for allegedly helping courier the packages to Star Health on behalf of xenZen.
Reuters was unable to identify the individual or the status of his detention.
Globally, health care companies have been reassessing the risks for their top executives after UnitedHealthcare Chief Executive Brian Thompson was murdered in a targeted attack in December. The killing also called fresh attention to deepening patient anger over health insurance.
In the March 31 email to Reuters, xenZen referred to the killing of Thompson and said the death threats to the Star Health executives were sent after the hacker was contacted for help by customers of Star Health who had been denied claims on medical bills despite coverage plans with the company.
Star Health did not comment on what xenZen described as their motive, the claims of dissatisfied customers being denied or the police investigation into the threats.
Star Health launched internal investigations into last year's data leak, which the company said followed a ransom demand of $68,000 from the hacker.
Star Health last September sued xenZen and messaging app Telegram for hosting the sensitive customer data on its chatbots, court papers show. The chatbots hosting the stolen data have since been deleted and the case is ongoing.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
18 minutes ago
- The Hindu
Call for region-specific antivenoms to save snakebite victims
Herpetologists and health experts have called for region-specific antivenoms to increase the chances of saving lives in areas where the 'Big Four' snakes are not dominant. Snakebite victims in India are administered a polyvalent antivenom derived from the venom of four serpents that cause the majority of deaths. These four are the Indian cobra (Naja naja), common krait (Bungarus caeruleus), Russell's viper (Daboia russelii), and saw-scaled viper (Echis carinatus). However, the polyvalent serum developed against these four snakes has limited or no efficacy in most parts of Northeastern India, where snakebite deaths are more commonly caused by the monocled cobra (Naja kaouthia), kraits (Bungarus sp.), green pit vipers (Trimeresurus sp.), and other medically significant snakes. 'There is an urgent need to establish a Regional Venom Centre and a serpentarium (a place where snakes are housed for exhibition or research) at a strategic place in the northeast to address the region's unique snakebite challenges and improve patient outcomes,' herpetologist Jayaditya Purkayastha said. He heads Help Earth, a Guwahati-based biodiversity conservation organisation, which partnered the Assam State Biodiversity Board, Assam Forest Department, and the Madras Crocodile Bank Trust (MCBT) to organise the first-ever Assam Snake Symposium a fortnight ago. The event brought together more than 80 snake rescuers from across Assam, alongside national and international experts, researchers, educators, and policymakers. 'Without region-specific antivenom, many envenomation cases result in delayed recovery, long-term complications, or even fatalities, despite the administration of standard treatment. A regional venom centre would serve as a hub for the systematic collection of venom from the medically important species native to the northeast, enabling the development of geographically appropriate antivenom,' Dr Purkayastha said. 'Such a centre, coupled with a serpentarium, can help maintain, milk, and study live specimens ethically. This facility would also support research on venom variability, toxin composition, and clinical manifestations specific to local snake species,' he said. High-burden States A 2020 study on trends in snakebite deaths in India from 2000 to 2019, published in eLife, said the World Health Organisation's call to halve global snakebite deaths by 2030 would require substantial progress in India. It also cited the WHO's estimation that 81,000-138,000 people die annually from snakebites worldwide, and thrice the number survive with amputations and permanent disabilities. The researchers of the study, including Romulus Whitaker, Wilson Suraweera, Geetha Menon, and Prabhat Jha, analysed 2,833 snakebite deaths from 611,483 verbal autopsies in the nationally representative Indian Million Death Study from 2001 to 2014, and conducted a systematic literature review from 2000 to 2019 covering 87,590 snakebites. The team estimated 1.2 million snakebite deaths (average 58,000 per year) across India from 2000 to 2019, nearly half of them occurring at ages 30-69 years and over a quarter in children under 15 years. Most of these deaths occurred at home in rural areas. The study found that about 70% occurred in eight higher-burden States with 55% of India's population, and half during the rainy season and at low altitude. These States are Bihar, Jharkhand, Madhya Pradesh, Odisha, Uttar Pradesh, Andhra Pradesh (before the creation of Telangana), Rajasthan, and Gujarat. 'The risk of an Indian dying from snakebite before age 70 is about 1 in 250, but notably higher in some areas. More crudely, we estimate 1.11-1.77 million bites in 2015, of which 70% showed symptoms of envenomation,' the study said, noting that prevention and treatment strategies might substantially reduce snakebite mortality in India. Overlooked health issue According to the National Crime Records Bureau's report on accidental deaths in 2022, deaths due to 'snakebite' dropped by 3.6% from 10,450 in 2021 to 10,085 the following year. Deaths due to 'killed by animals' and 'animal/reptiles/insects bite' increased by 16.5% and 16.7% during this period, respectively. Despite the 'encouraging' trend in snakebite deaths, reptile specialists pointed out that snakebite envenoming remains a major but often overlooked public health issue in India, which accounts for nearly half of the global snakebite deaths each year. 'India is the world's most affected nation in terms of mortality. The burden is particularly high in rural and agrarian communities, where people frequently work barefoot in fields and lack access to timely medical care,' MCBT's Gnaneswar Ch. said. He said that the snakebite crisis is worsened by several challenges, with many cases going unreported due to reliance on traditional healers, lack of transportation, and limited awareness. 'Delays in reaching health facilities, along with improper first-aid practices, often lead to severe complications or death. Furthermore, there is a shortage of trained personnel and adequate supplies of antivenom in remote areas. The quality and regional suitability of antivenom is another concern, as it may not be effective against locally prevalent snake species outside the Big Four,' he said. In response to this public health emergency, India launched the National Action Plan for Prevention and Control of Snakebite Envenoming in 2024, aligning with the WHO's 2030 target to halve snakebite deaths. The experts agreed that despite such efforts, major gaps remain in public awareness, community preparedness, and healthcare infrastructure. They sought greater emphasis on region-specific research, education campaigns at the village level, and strengthening rural healthcare systems to ensure early and appropriate treatment. Snakebite mitigation Acknowledging the challenges in saving lives in a region where the polyvalent serum is less effective, Assam's forest minister, Chandra Mohan Patowary said a State-Level Steering Committee on Snakebite Mitigation would be formed. He proposed the establishment of a serpentarium in Assam to facilitate advanced research on snake venom and address the region-specific challenges of envenomation and treatment. Subsequently, the Assam State Biodiversity Board signed a memorandum of understanding with Help Earth to work jointly on snakebite awareness and mitigation programmes at the Biodiversity Management Committee level. The experts favoured a State Snakebite Mitigation Action Plan toward setting up a Regional Venom Centre and facilitating collaborations with institutions across India for venomics research and antivenom standardisation. They also suggested an app or digital platform for the timely and ethical handling of snake-human encounters, increasing due to habitat encroachment, urbanisation, and seasonal flooding. Such an app is envisaged to serve as a life-saving tool for both humans and snakes by reducing panic and delays during snake sightings or bite incidents. 'Beyond rescue logistics, the app can act as a centralised repository of real-time data on snake rescue, release locations, species involved, and conflict zones. This valuable information can be used to identify hotspots, monitor trends, and guide policy-level decisions for snake conservation, land-use planning, and public health interventions,' Dr Purkayastha said. 'Moreover, this digital platform can be integrated with hospitals, forest departments, and wildlife boards to streamline responses, improve awareness, and encourage coexistence,' he said. 'Snakebite deaths in India are largely preventable, and with coordinated action across health, forest, and community sectors, the country can move closer to eliminating avoidable snakebite fatalities,' Assam's chief wildlife warden, Vinay Gupta, said.
Economic Times
an hour ago
- Economic Times
Apple Watch blood oxygen feature returns: Stunning update rolls out with iOS 18.6.1 and watchOS 11.6.1. How can you access it?
Synopsis Apple will introduce a redesigned Blood Oxygen feature for some Apple Watch Series 9, Series 10, and Apple Watch Ultra 2 users through an iPhone and Apple Watch software update, the tech giant said on Thursday. The feature typically allows users to see a readout of their blood oxygen level right on the Apple Watch. Reuters Apple is rolling out a software update that enables a redesigned version of the feature for the Apple Watch Series 9, 10, and Ultra 2 that circumvents the import ban imposed by the International Trade Commission Tech giant Apple is bringing blood oxygen detection back to its latest smartwatches after the company was forced to stop offering the feature on US models over a patent dispute. The blood oxygen feature will come to Apple Watch Series 9, Series 10 and Ultra 2 models in the US currently missing the functionality through a software update, the company said in a statement. This feature is meant to help people understand their respiratory is rolling out a software update that enables a redesigned version of the feature for the Apple Watch Series 9, 10, and Ultra 2 that circumvents the import ban imposed by the International Trade Commission. To get around the ban, blood oxygen data collected on the Apple Watch will now be measured and calculated on the iPhone that it is paired to. While users won't be able to view the data on their wrist, they'll be able to view it in the iPhone's Health app under the Respiratory section. iOS 18.6.1 can be downloaded on eligible iPhones over-the-air by going to Settings > General > Software Update. watchOS 11.6.1 is available for newer Apple Watch models that have blood oxygen monitoring disabled, and it can be downloaded through the Apple Watch app on the iPhone. ALSO READ: iPhone 17 pro release date revealed? Here's when to expect Apple's big launch. Will you have to pay higher prices? This marks the latest development in a years-long saga that saw Apple temporarily yank its popular smartwatches from US store shelves during the critical holiday season nearly two years ago. In 2023, the International Trade Commission ruled that Apple had violated a patent from digital health company Masimo related to its pulse oximeter technology, which Apple denied the order was issued, it applied only to new Apple Watches in the United States, meaning those who already owned an Apple Watch with the feature were unaffected. Apple Watches sold outside the United States were also unaffected by the order. Now, Apple has found a workaround and is restoring it through the new iOS 18.6.1 and watchOS 11.6.1 updates. Apple's decision to release the update follows a fresh US Customs ruling that allows the company to import watches with a redesigned version of the READ: Video captures massive explosion in New York: Black smoke engulfs Manhattan skyline Users with models Series 9, Series 10, and Apple Watch Ultra 2 in the US who currently do not have the Blood Oxygen feature will have access to the redesigned Blood Oxygen feature by updating their paired iPhone to iOS 18.6.1 and their Apple Watch to watchOS this update, sensor data from the Blood Oxygen app on Apple Watch will be measured and calculated on the paired iPhone, and results can be viewed in the Respiratory section of the Health app, the company said. This update was enabled by a recent U.S. Customs will be no impact to Apple Watch units previously purchased that include the original Blood Oxygen feature, nor to Apple Watch units purchased outside of the U.S. ALSO READ: Video shows Barron Trump's childhood confession: US President's son was just 18-month old when he predicted his future In the US, users of these Apple Watch models who don't currently have the Blood Oxygen feature can get the redesigned version by updating their iPhone to iOS 18.6.1 and Apple Watch to watchOS the latest update, the Blood Oxygen app on Apple Watch now sends its data to the paired iPhone for processing. The results will be displayed in the Health app under the Respiratory section. This change comes in response to a US Customs ruling. In simple terms, Apple Watch users in the US can once again measure their blood oxygen levels directly on their watch, but the detailed results will only appear on the iPhone. Watches that were sold with the original feature, or those purchased outside the US, remain unaffected.
Time of India
an hour ago
- Time of India
72-year-old woman holds drip bottle for 30 minutes for injured grandson at Satna Hospital, staff accused of negligence
A 72-year-old woman in Madhya Pradesh 's Satna had to hold a drip bottle for nearly 30 minutes for her injured grandson at Sardar Vallabhbhai Patel District Hospital after staff failed to provide a drip stand. Independence Day 2025 Modi signals new push for tech independence with local chips Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji Subhas Chandra Bose gave India its own currency The incident occurred on Friday when 35-year-old Ashwani Mishra, injured in a road accident in Maihar, was brought to the hospital. Despite his critical condition, no drip stand was provided, forcing his grandmother to hold the bottle while hospital staff stood by. Eyewitnesses claimed there was no shortage of stands in the facility and blamed the ordeal on staff negligence. The sight of the frail elderly woman struggling yet determined to keep the drip flowing left bystanders both shocked and angered. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Undo The situation was further aggravated by the poor condition of the ambulance that transported Mishra. After dropping him off at the hospital gate, the vehicle broke down and had to be pushed by locals to get it moving again. This incident adds to mounting complaints about the hospital's poor infrastructure. Despite handling hundreds of patients daily, the facility has often been criticized for failing to provide basic amenities such as stretchers, beds, and timely assistance. Live Events Civil Surgeon Manoj Shukla, however, played down the matter, saying, "There is no shortage of stands. The patient was brought in an ambulance, and within 5-7 minutes treatment was provided. The grandmother herself picked up the drip, but the patient has been treated properly."
